Codexis (CDXS) Cash from Financing Activities (2010 - 2026)

Codexis (CDXS) recorded quarterly Cash from Financing Activities of -$14000.0 in Q1 2026, down 107.78% quarter-over-quarter from $180000.0 in Q4 2025, and down 101.29% on a YoY basis from $1.1 million in Q1 2025.

Codexis (CDXS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Codexis' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$14000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 101.29% year-over-year to -$14000.0; the TTM figure through Mar 2026 stood at $26.8 million (down 17.0% YoY), while the FY2025 annual figure was $27.9 million, down 53.85% from the prior year.
  • Cash from Financing Activities was -$14000.0 for Q1 2026 at Codexis, down from $180000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $30.3 million in Q3 2024 to a low of -$1.3 million in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $6.0 million across 5 years, with a median of $286000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 7629.41% in 2022, then jumped 28161.11% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $339000.0 in 2022, then plunged by 131.86% to -$108000.0 in 2023, then surged by 1148.15% to $1.1 million in 2024, then sank by 84.1% to $180000.0 in 2025, then sank by 107.78% to -$14000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$14000.0 (Q1 2026), $180000.0 (Q4 2025), and -$111000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 7.00 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 53,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -538.80 Mn
9 Abivax 95.45 Bn 95.45 Bn - 85,464.43
10 Codexis 226.01 Mn 160.87 Mn 13.18 Mn -14,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -14,000.00
Mar 31, 2026 -14,000.00
Dec 31, 2025 180,000.00
Dec 31, 2025 180,000.00
Sep 30, 2025 -111,000.00
Sep 30, 2025 -111,000.00
Jun 30, 2025 26.77 Mn
Jun 30, 2025 26.77 Mn
Mar 31, 2025 1.09 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 1.13 Mn
Dec 31, 2024 1.13 Mn
Sep 30, 2024 30.31 Mn
Sep 30, 2024 30.31 Mn
Jun 30, 2024 -197,000.00
Jun 30, 2024 -197,000.00
Mar 31, 2024 29.28 Mn
Mar 31, 2024 29.28 Mn
Sep 30, 2023 -108,000.00
Sep 30, 2023 -108,000.00